Development, verification, and validation of computer models of cardiac fibrillation

心脏颤动计算机模型的开发、验证和验证

• 批准号: 1347015
• 负责人: Flavio Fenton
• 金额: $ 9.06万
• 依托单位: Georgia Tech Research Corporation
• 依托单位国家: 美国
• 项目类别: Standard Grant
• 财政年份: 2013
• 资助国家: 美国
• 起止时间: 2013-10-01 至 2015-09-30
• 项目状态: 已结题
• 来源: https://www.nsf.gov/awardsearch/showAward?AWD_ID=1347015&HistoricalAwards=false
• 关键词: Development; verification; validation; computer; models

This NSF-FDA Scholar-In-Residence award supports translational research in modeling to inform future medical device design and approval processes. It is supported by the NSF Cyber-Physical Systems program in the Division of Computer and Network Systems in the Directorate for Computer and Information Science and Engineering.Sudden cardiac death is the leading cause of fatalities in the industrialized world. One in five people in the United States is affected by some sort of heart disease and one third of all deaths are due to cardiac diseases with an economic impact of about $200 billion a year. Most of these deaths result from arrhythmias, particularly fibrillation, which is rapid, disorganized electrical activity. The classification of arrhythmias as either reentrant or focal is of clinical significance, yet is difficult to assess. The FDA is responsible for regulating the systems and algorithms that aim to make this important differentiation. Such differentiation is a complex task involving the analysis of complex spatio-temporal patterns of electrical activity. The objectives of this project are to identify the key features of fibrillation that models should represent, to compare how well (or poorly) existing models correspond to measured values of these features, and to develop models that better represent fibrillation. The project develops and extends cell and tissue models and explores the analysis of clinical, experimental and simulation data from the perspective of regulatory science at the FDA, including verification, validation, and uncertainty quantification (VVUQ). The project seeks to 1) validate and create new models that reproduce not only single-cell dynamics, but also experimental and clinically relevant physiological dynamics in tissue and 2) initiate a new developmental framework that the FDA can use not only to test cardiac electrophysiology devices but also to characterize and verify massive submissions of therapeutic compounds obtained by computer-aided drug design methods. The research is conducted in collaboration with the Center for Devices and Radiological Health at FDA, and is aimed at developing tools that can characterize and evaluate real-world performance of devices. This will help the FDA to better regulate and verify the safety and effectiveness of devices that are developed to treat and terminate cardiac arrhythmias. All results from this project will be made freely available to the research community and to the general public.

该NSF-FDA居住学者奖支持转化研究，以告知未来的医疗设备设计和批准过程。 它得到了计算机和信息科学与工程局的计算机和网络系统部门的NSF网络物理系统计划的支持。Sudden心脏死亡是工业化世界死亡的主要原因。美国五分之一的人受某种心脏病的影响，所有死亡人数中有三分之一是由于心脏病的经济影响约为2000亿美元。这些死亡大多数是由于心律不齐而导致的，尤其是纤颤，这是快速，混乱的电活动。心律不齐为重入或局灶性的分类具有临床意义，但很难评估。 FDA负责调节旨在使这种重要差异化的系统和算法。这种分化是一项复杂的任务，涉及对电活动的复杂时空模式的分析。该项目的目标是确定模型应代表的纤颤的关键特征，以比较现有模型与这些特征的测量值相对应，并开发更好代表纤颤的模型。该项目从FDA的监管科学的角度来开发和扩展细胞和组织模型，并探讨了临床，实验和模拟数据的分析，包括验证，验证和不确定性定量（VVUQ）。 The project seeks to 1) validate and create new models that reproduce not only single-cell dynamics, but also experimental and clinically relevant physiological dynamics in tissue and 2) initiate a new developmental framework that the FDA can use not only to test cardiac electrophysiology devices but also to characterize and verify massive submissions of therapeutic compounds obtained by computer-aided drug design methods.该研究是与FDA的设备和放射学中心合作进行的，旨在开发可以表征和评估设备真实性能的工具。这将有助于FDA更好地调节和验证为治疗和终止心律不齐的设备的安全性和有效性。该项目的所有结果将免费提供给研究社区和公众。